CHARLES WYKOFF

Concepts (522)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Diabetic Retinopathy
78
2025
162
22.840
Why?
Angiogenesis Inhibitors
103
2025
219
19.280
Why?
Macular Edema
57
2025
92
15.760
Why?
Visual Acuity
111
2025
705
14.690
Why?
Wet Macular Degeneration
36
2025
44
10.810
Why?
Macular Degeneration
33
2025
127
10.450
Why?
Ranibizumab
61
2025
75
10.430
Why?
Vascular Endothelial Growth Factor A
89
2025
446
10.000
Why?
Receptors, Vascular Endothelial Growth Factor
51
2024
102
9.420
Why?
Intravitreal Injections
101
2025
148
9.390
Why?
Tomography, Optical Coherence
91
2025
561
8.830
Why?
Recombinant Fusion Proteins
52
2025
801
8.670
Why?
Fluorescein Angiography
69
2025
152
7.580
Why?
Geographic Atrophy
17
2025
24
7.490
Why?
Macula Lutea
19
2025
48
5.310
Why?
Retinal Diseases
18
2024
180
4.880
Why?
Retinal Detachment
16
2025
79
4.820
Why?
Diabetes Mellitus
19
2024
930
4.660
Why?
Vitrectomy
26
2025
91
4.640
Why?
Antibodies, Monoclonal, Humanized
23
2024
551
4.390
Why?
Retinal Vein Occlusion
17
2022
27
4.340
Why?
Retinal Vessels
24
2024
78
4.330
Why?
Choroidal Neovascularization
12
2023
34
4.220
Why?
Retinal Perforations
10
2024
25
3.670
Why?
Laser Coagulation
17
2023
128
3.530
Why?
Bevacizumab
20
2024
79
2.910
Why?
Retina
22
2023
499
2.510
Why?
Choroid
9
2025
41
2.320
Why?
Humans
250
2025
133390
2.170
Why?
Aged
98
2025
21605
2.150
Why?
Scleral Buckling
9
2022
14
2.120
Why?
Glucocorticoids
10
2024
401
2.030
Why?
Endophthalmitis
7
2016
69
2.020
Why?
Middle Aged
105
2025
29208
2.020
Why?
Follow-Up Studies
43
2025
5455
1.940
Why?
Aged, 80 and over
49
2025
7159
1.790
Why?
Fundus Oculi
21
2025
67
1.750
Why?
Prospective Studies
48
2025
6570
1.700
Why?
Male
124
2025
65685
1.630
Why?
Photography
6
2022
88
1.620
Why?
Treatment Outcome
58
2025
12971
1.610
Why?
Female
129
2025
71455
1.570
Why?
Peptides, Cyclic
2
2023
57
1.540
Why?
Ischemia
10
2021
383
1.470
Why?
Retinal Pigment Epithelium
6
2025
38
1.340
Why?
Retrospective Studies
59
2025
17378
1.330
Why?
Vitreous Detachment
3
2024
11
1.320
Why?
Complement Inactivating Agents
4
2023
12
1.310
Why?
Complement C3
4
2023
54
1.250
Why?
Fovea Centralis
4
2020
10
1.160
Why?
Endothelial Growth Factors
12
2023
54
1.160
Why?
Eye Infections, Bacterial
3
2016
86
1.150
Why?
Retinal Vasculitis
4
2023
8
1.130
Why?
Triamcinolone Acetonide
4
2024
36
1.110
Why?
Subretinal Fluid
7
2024
11
1.060
Why?
Double-Blind Method
16
2025
1654
1.060
Why?
Nerve Fibers
3
2025
79
0.990
Why?
Retinal Telangiectasis
3
2025
5
0.990
Why?
Epiretinal Membrane
4
2024
14
0.960
Why?
Adult
52
2025
31786
0.940
Why?
Peripherins
1
2024
2
0.930
Why?
Disease Progression
15
2025
2237
0.920
Why?
Fluocinolone Acetonide
4
2020
6
0.880
Why?
Vitreous Body
5
2024
101
0.850
Why?
Cataract
3
2022
174
0.850
Why?
ATP-Binding Cassette Transporters
1
2024
197
0.840
Why?
Cysts
2
2024
104
0.840
Why?
Retinal Vein
3
2022
11
0.820
Why?
Ophthalmology
6
2024
198
0.800
Why?
Angiopoietin-2
4
2024
16
0.790
Why?
Drug Delivery Systems
3
2025
232
0.790
Why?
Clinical Trials as Topic
5
2023
1153
0.780
Why?
Benchmarking
1
2023
146
0.780
Why?
Eye Infections, Fungal
4
2014
73
0.770
Why?
Antibodies, Bispecific
2
2024
51
0.760
Why?
Edema
2
2022
140
0.730
Why?
Carbonic Anhydrases
11
2003
26
0.720
Why?
Cataract Extraction
3
2017
155
0.710
Why?
Neovascularization, Pathologic
7
2018
263
0.700
Why?
Ophthalmoscopy
3
2019
29
0.700
Why?
Ophthalmic Solutions
2
2011
90
0.700
Why?
No-Show Patients
1
2020
3
0.670
Why?
Basement Membrane
5
2024
48
0.670
Why?
Vitreoretinal Surgery
2
2021
6
0.670
Why?
Vision Disorders
4
2023
221
0.670
Why?
Lost to Follow-Up
1
2020
33
0.660
Why?
Retinal Hemorrhage
2
2017
26
0.650
Why?
Sensory Thresholds
1
2019
38
0.640
Why?
Patient Dropouts
1
2019
52
0.640
Why?
Anti-Inflammatory Agents
2
2019
315
0.630
Why?
Postoperative Complications
4
2017
3155
0.630
Why?
Time Factors
12
2025
6569
0.610
Why?
Choroid Diseases
1
2019
23
0.610
Why?
Eye Diseases
2
2011
130
0.590
Why?
Microaneurysm
3
2023
3
0.570
Why?
Monitoring, Physiologic
1
2020
388
0.570
Why?
Retinal Degeneration
3
2025
104
0.550
Why?
Lasers
2
2017
115
0.530
Why?
Patient Compliance
1
2019
477
0.510
Why?
Drug Administration Schedule
6
2022
755
0.510
Why?
Lasers, Solid-State
1
2016
17
0.500
Why?
Biomarkers
11
2025
3424
0.500
Why?
Meningoencephalitis
1
2016
22
0.490
Why?
Retinitis
1
2016
18
0.490
Why?
Anti-Bacterial Agents
5
2019
2509
0.470
Why?
Randomized Controlled Trials as Topic
7
2024
1210
0.470
Why?
Antibiotic Prophylaxis
1
2016
126
0.470
Why?
Silicone Oils
2
2025
8
0.470
Why?
Atrophy
7
2025
251
0.460
Why?
Vancomycin
1
2017
235
0.450
Why?
Waldenstrom Macroglobulinemia
1
2018
154
0.450
Why?
Cell Hypoxia
12
2004
104
0.450
Why?
Povidone-Iodine
2
2011
10
0.450
Why?
Clinical Protocols
5
2022
245
0.450
Why?
Mutation
3
2025
6290
0.450
Why?
Injections, Intraocular
3
2024
10
0.440
Why?
West Nile Fever
1
2016
139
0.430
Why?
Central Serous Chorioretinopathy
2
2025
8
0.430
Why?
Cryosurgery
1
2013
48
0.420
Why?
Fungi
3
2014
75
0.410
Why?
Carcinoma, Renal Cell
4
2004
253
0.410
Why?
Precision Medicine
2
2018
355
0.410
Why?
Retinal Ganglion Cells
2
2025
120
0.410
Why?
Uveitis
2
2024
38
0.400
Why?
Choroid Neoplasms
2
2013
25
0.390
Why?
Vitreoretinopathy, Proliferative
2
2022
7
0.380
Why?
Transcription Factors
10
2004
2704
0.380
Why?
Nuclear Proteins
9
2004
1334
0.380
Why?
Antisepsis
1
2011
7
0.380
Why?
Mycoses
2
2014
119
0.370
Why?
Ophthalmologists
2
2024
14
0.370
Why?
Ciliary Body
1
2011
28
0.360
Why?
Bacteria
2
2016
533
0.360
Why?
Eye
2
2024
245
0.360
Why?
Young Adult
9
2025
9852
0.360
Why?
Retinal Neovascularization
3
2020
17
0.360
Why?
Surgical Wound Infection
2
2017
273
0.350
Why?
Endotamponade
3
2025
7
0.350
Why?
Ubiquitin-Protein Ligases
3
2004
388
0.350
Why?
Kidney Neoplasms
4
2004
461
0.350
Why?
Tumor Suppressor Proteins
3
2004
509
0.350
Why?
Retinitis Pigmentosa
2
2025
95
0.350
Why?
Uveal Neoplasms
1
2011
60
0.340
Why?
Retreatment
4
2018
92
0.340
Why?
Algorithms
6
2024
1729
0.340
Why?
Retinal Drusen
3
2024
6
0.340
Why?
Regression Analysis
3
2022
825
0.340
Why?
Aging
1
2018
1297
0.340
Why?
Surgical Flaps
2
2024
196
0.340
Why?
Diagnosis, Differential
3
2024
1968
0.340
Why?
Hospitals, University
1
2010
105
0.330
Why?
Antibodies, Monoclonal
3
2019
1068
0.330
Why?
Cephalosporins
1
2011
143
0.330
Why?
Neoplasm Proteins
10
2004
716
0.330
Why?
Regional Blood Flow
3
2019
226
0.320
Why?
Drug Hypersensitivity
1
2011
100
0.320
Why?
Pharmaceutical Preparations
3
2023
91
0.310
Why?
Monitoring, Intraoperative
1
2010
134
0.310
Why?
Cryptococcosis
1
2009
44
0.310
Why?
Quality of Life
4
2023
2137
0.310
Why?
Oculomotor Nerve
1
2008
7
0.300
Why?
DNA-Binding Proteins
8
2004
2161
0.300
Why?
Cranial Nerve Neoplasms
1
2008
8
0.300
Why?
Capillary Permeability
2
2020
77
0.300
Why?
Drug Therapy, Combination
4
2025
1193
0.300
Why?
Oculomotor Nerve Diseases
1
2008
18
0.300
Why?
Eye Injuries, Penetrating
1
2008
17
0.290
Why?
Blindness
2
2021
76
0.290
Why?
Risk Factors
11
2024
11085
0.290
Why?
Exudates and Transudates
2
2021
22
0.290
Why?
Rhabdoid Tumor
1
2008
56
0.290
Why?
Adolescent
7
2024
20505
0.290
Why?
Antigens, Neoplasm
8
2003
407
0.280
Why?
Corneal Ulcer
1
2008
55
0.280
Why?
Combined Modality Therapy
8
2020
1306
0.280
Why?
Vitelliform Macular Dystrophy
2
2024
2
0.280
Why?
Single-Blind Method
2
2021
248
0.270
Why?
Teratoma
1
2008
130
0.270
Why?
Cross Infection
1
2010
332
0.270
Why?
Practice Guidelines as Topic
3
2024
1334
0.260
Why?
Gene Expression Regulation, Neoplastic
4
2002
2120
0.250
Why?
Keratomileusis, Laser In Situ
1
2006
97
0.240
Why?
Severity of Illness Index
5
2021
3082
0.240
Why?
Hexokinase
1
2025
24
0.240
Why?
Myopia
1
2006
132
0.230
Why?
Cross-Sectional Studies
7
2024
3733
0.230
Why?
Gene Expression Profiling
2
2004
1918
0.230
Why?
United States
9
2024
11677
0.230
Why?
Biomarkers, Tumor
7
2008
1717
0.230
Why?
Melanoma
2
2013
964
0.230
Why?
Intraocular Pressure
2
2024
136
0.230
Why?
Aqueous Humor
2
2022
28
0.220
Why?
Oxygen
6
2018
577
0.220
Why?
Angiopoietins
2
2021
21
0.220
Why?
Drug Approval
1
2024
45
0.220
Why?
Complement C5
1
2023
7
0.220
Why?
Cross-Over Studies
1
2025
328
0.220
Why?
Carcinoma, Intraductal, Noninfiltrating
2
2002
74
0.210
Why?
Ligases
2
2000
48
0.210
Why?
Cyclin D1
1
2004
123
0.210
Why?
Tumor Cells, Cultured
9
2004
1102
0.210
Why?
Hypoxia
4
2004
263
0.210
Why?
Entropy
1
2023
29
0.210
Why?
United States Food and Drug Administration
1
2024
158
0.210
Why?
Meta-Analysis as Topic
1
2024
173
0.210
Why?
Photochemotherapy
2
2022
44
0.210
Why?
Biosimilar Pharmaceuticals
1
2023
6
0.210
Why?
Aptamers, Nucleotide
1
2023
35
0.210
Why?
Drainage
1
2025
264
0.210
Why?
Evidence-Based Medicine
2
2024
677
0.210
Why?
Traction
1
2022
9
0.200
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
9
2004
104
0.200
Why?
Drug Resistance
2
2013
264
0.200
Why?
Eye Neoplasms
2
2013
53
0.190
Why?
Prone Position
1
2022
33
0.190
Why?
Hypoxia-Inducible Factor 1
8
2004
19
0.190
Why?
Porphyrins
1
2022
18
0.190
Why?
Delphi Technique
1
2023
243
0.190
Why?
Polyethylene Glycols
1
2023
252
0.190
Why?
Imaging, Three-Dimensional
1
2024
394
0.190
Why?
Biomedical Research
2
2019
555
0.180
Why?
Equipment Design
2
2020
604
0.180
Why?
Carcinoma, Non-Small-Cell Lung
4
2012
377
0.180
Why?
Cornea
1
2006
594
0.180
Why?
Postoperative Period
2
2020
341
0.180
Why?
Confidence Intervals
1
2021
300
0.180
Why?
Blood-Retinal Barrier
2
2020
3
0.180
Why?
Drug Implants
2
2020
43
0.180
Why?
Computer Systems
1
2021
38
0.180
Why?
Dose-Response Relationship, Drug
4
2020
1733
0.170
Why?
Registries
3
2023
1568
0.170
Why?
Videoconferencing
1
2020
22
0.170
Why?
Cytokines
3
2022
1393
0.170
Why?
Surgery, Computer-Assisted
2
2020
64
0.170
Why?
Patient Reported Outcome Measures
1
2022
204
0.160
Why?
Fractals
1
2019
2
0.160
Why?
Receptor, Platelet-Derived Growth Factor beta
1
2019
20
0.160
Why?
Consensus
1
2023
737
0.160
Why?
Microcirculation
2
2019
116
0.160
Why?
Income
1
2020
140
0.160
Why?
Recurrence
3
2019
1464
0.160
Why?
Congresses as Topic
1
2020
187
0.160
Why?
Biological Products
1
2021
137
0.150
Why?
Insurance Coverage
1
2020
124
0.150
Why?
Early Diagnosis
1
2019
197
0.150
Why?
Longitudinal Studies
2
2022
1493
0.150
Why?
Antifungal Agents
3
2014
306
0.150
Why?
Delayed-Action Preparations
1
2018
125
0.150
Why?
Cost-Benefit Analysis
1
2021
561
0.150
Why?
Continuity of Patient Care
1
2020
153
0.150
Why?
Diagnostic Techniques, Ophthalmological
1
2019
86
0.140
Why?
Necrosis
7
2004
221
0.140
Why?
Vision, Low
1
2017
15
0.140
Why?
Visual Prosthesis
1
2017
6
0.140
Why?
Proteins
2
2000
1087
0.140
Why?
Ultrasonography
3
2024
997
0.140
Why?
Breast Neoplasms
5
2004
2762
0.140
Why?
Betacoronavirus
1
2020
304
0.130
Why?
Drug and Narcotic Control
1
2016
16
0.130
Why?
Legislation, Drug
1
2016
9
0.130
Why?
Prosthesis Implantation
1
2017
143
0.130
Why?
Beryllium
1
2016
3
0.130
Why?
Administration, Topical
1
2016
142
0.130
Why?
Cohort Studies
6
2022
5175
0.120
Why?
Genes, Tumor Suppressor
3
2002
225
0.120
Why?
Therapeutic Equivalency
1
2015
13
0.120
Why?
Patient Acceptance of Health Care
1
2020
471
0.120
Why?
Photoreceptor Cells, Vertebrate
1
2015
41
0.120
Why?
Coronavirus Infections
1
2020
383
0.120
Why?
Pneumonia, Viral
1
2020
394
0.120
Why?
Lung Neoplasms
4
2012
1787
0.110
Why?
Medication Adherence
1
2018
338
0.110
Why?
Vascular Endothelial Growth Factors
3
2023
53
0.110
Why?
Von Hippel-Lindau Tumor Suppressor Protein
3
2004
37
0.110
Why?
Fluconazole
2
2014
50
0.110
Why?
Amphotericin B
2
2014
91
0.100
Why?
von Hippel-Lindau Disease
3
2002
20
0.100
Why?
History, 18th Century
1
2013
70
0.100
Why?
Practice Patterns, Physicians'
1
2019
765
0.100
Why?
Electronic Health Records
1
2020
792
0.100
Why?
Carbonic Anhydrase IX
8
2003
13
0.100
Why?
Observational Studies as Topic
2
2023
103
0.100
Why?
Anterior Chamber
1
2012
33
0.090
Why?
Electroretinography
2
2025
123
0.090
Why?
Blood Glucose
1
2016
1189
0.090
Why?
Chlorhexidine
1
2011
47
0.090
Why?
Telemedicine
1
2018
500
0.090
Why?
Lymphokines
2
2002
69
0.090
Why?
Refraction, Ocular
1
2013
217
0.090
Why?
Drug Costs
1
2011
66
0.090
Why?
Liver Function Tests
1
2011
107
0.090
Why?
Retinopathy of Prematurity
1
2011
64
0.090
Why?
Age Factors
1
2018
2984
0.090
Why?
Laser Therapy
1
2013
227
0.090
Why?
Glucose
1
2015
923
0.090
Why?
Florida
1
2010
79
0.080
Why?
Decision Making
1
2015
698
0.080
Why?
Acute Disease
2
2010
1190
0.080
Why?
Penicillins
1
2011
155
0.080
Why?
Prognosis
7
2024
5074
0.080
Why?
Signal Transduction
3
2021
4897
0.080
Why?
Neoplasms
2
2004
3024
0.080
Why?
Child
3
2024
25733
0.080
Why?
Flucytosine
1
2009
17
0.080
Why?
Cryptococcus neoformans
1
2009
23
0.080
Why?
Immunohistochemistry
6
2003
1760
0.080
Why?
Clinical Trials, Phase III as Topic
2
2021
76
0.080
Why?
Intraoperative Complications
1
2010
162
0.080
Why?
In Situ Hybridization
4
2004
484
0.080
Why?
Meningeal Carcinomatosis
1
2008
5
0.080
Why?
Preoperative Care
1
2011
368
0.080
Why?
Subarachnoid Space
1
2008
25
0.080
Why?
Diagnostic Imaging
1
2011
317
0.080
Why?
Mesencephalon
1
2008
38
0.070
Why?
Neoplasm Invasiveness
2
2008
667
0.070
Why?
Eye Enucleation
1
2008
50
0.070
Why?
Incidence
1
2016
3396
0.070
Why?
Keratoplasty, Penetrating
1
2008
51
0.070
Why?
Reproducibility of Results
3
2020
3025
0.070
Why?
Fatal Outcome
1
2008
376
0.070
Why?
Treatment Failure
1
2008
364
0.070
Why?
Blotting, Western
4
2003
1134
0.070
Why?
Carcinoma, Squamous Cell
3
2001
872
0.070
Why?
Case-Control Studies
2
2024
3642
0.070
Why?
Urinary Bladder Neoplasms
2
2002
557
0.060
Why?
Body Weights and Measures
1
2006
41
0.060
Why?
Capillaries
2
2017
70
0.060
Why?
Neurosurgical Procedures
1
2008
317
0.060
Why?
Head and Neck Neoplasms
2
2001
699
0.060
Why?
Hydrocephalus
1
2008
275
0.060
Why?
Pilot Projects
2
2020
1481
0.060
Why?
Transfection
3
2004
1089
0.060
Why?
Phenotype
3
2025
4551
0.060
Why?
Magnetic Resonance Imaging
2
2024
3839
0.060
Why?
Basic Helix-Loop-Helix Transcription Factors
3
2003
406
0.060
Why?
Immunoblotting
2
2004
317
0.060
Why?
Suspensions
1
2024
10
0.060
Why?
Search Engine
1
2023
10
0.050
Why?
Pandemics
2
2023
1189
0.050
Why?
Organic Chemicals
1
2023
60
0.050
Why?
Plasmids
2
2004
526
0.050
Why?
RNA, Messenger
4
2004
2899
0.050
Why?
Vitreous Hemorrhage
1
2023
9
0.050
Why?
Equivalence Trials as Topic
1
2023
14
0.050
Why?
Vascular Endothelial Growth Factor C
1
2023
10
0.050
Why?
Inflammation
2
2022
1590
0.050
Why?
DNA Mutational Analysis
1
2025
838
0.050
Why?
Nephrons
1
2002
21
0.050
Why?
Neurofibromin 2
1
2022
11
0.050
Why?
Indocyanine Green
2
2015
62
0.050
Why?
Adenocarcinoma, Clear Cell
1
2002
25
0.050
Why?
Syringes
1
2022
25
0.050
Why?
Cell Division
2
2001
773
0.050
Why?
Photosensitizing Agents
1
2022
38
0.050
Why?
Up-Regulation
2
2004
905
0.050
Why?
Data Interpretation, Statistical
1
2023
239
0.050
Why?
Pentosan Sulfuric Polyester
1
2021
1
0.050
Why?
Cell Adhesion Molecule-1
1
2021
1
0.050
Why?
Monocyte Chemoattractant Proteins
1
2021
9
0.050
Why?
Canada
1
2022
343
0.050
Why?
Neoplasm Recurrence, Local
1
2008
1313
0.050
Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2021
29
0.050
Why?
Urokinase-Type Plasminogen Activator
1
2021
39
0.050
Why?
Tissue Inhibitor of Metalloproteinase-1
1
2021
40
0.050
Why?
Sensitivity and Specificity
2
2019
2160
0.040
Why?
Pedigree
1
2025
1694
0.040
Why?
Genetic Association Studies
1
2025
844
0.040
Why?
RNA
2
2004
600
0.040
Why?
Helix-Loop-Helix Motifs
1
2001
43
0.040
Why?
Ribonucleases
1
2000
51
0.040
Why?
Oligonucleotide Array Sequence Analysis
2
2002
1070
0.040
Why?
Iatrogenic Disease
1
2021
132
0.040
Why?
Radiation-Sensitizing Agents
1
2000
28
0.040
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2008
1349
0.040
Why?
Extracellular Space
1
2001
89
0.040
Why?
Antigens, Nuclear
1
2001
57
0.040
Why?
Carcinoma, Ductal, Breast
1
2001
91
0.040
Why?
Organ Size
1
2022
466
0.040
Why?
Multicenter Studies as Topic
1
2021
289
0.040
Why?
Machine Learning
1
2024
334
0.040
Why?
Slit Lamp Microscopy
1
2020
6
0.040
Why?
Antibody Specificity
1
2001
206
0.040
Why?
Saccharomyces cerevisiae Proteins
1
2002
283
0.040
Why?
Nitroimidazoles
1
2000
44
0.040
Why?
Liver Neoplasms
1
2011
1411
0.040
Why?
Half-Life
1
2020
160
0.040
Why?
Observation
1
2020
45
0.040
Why?
Erythropoietin
1
2001
110
0.040
Why?
Trans-Activators
2
2001
830
0.040
Why?
Homeodomain Proteins
1
2003
584
0.040
Why?
Immunoglobulin Fab Fragments
1
2019
65
0.040
Why?
Protein Isoforms
1
2001
429
0.040
Why?
Genes, Reporter
1
2000
394
0.040
Why?
Breast
1
2001
218
0.040
Why?
Calcinosis
1
2001
193
0.040
Why?
Repressor Proteins
1
2004
869
0.040
Why?
Promoter Regions, Genetic
2
2000
1417
0.040
Why?
Medicare
1
2023
463
0.040
Why?
Genetic Therapy
1
2024
733
0.040
Why?
Interleukin-6
1
2021
449
0.040
Why?
Protein Binding
2
2020
1832
0.040
Why?
Cells
1
1999
25
0.040
Why?
Image Interpretation, Computer-Assisted
1
2020
234
0.040
Why?
Genotype
1
2025
2804
0.040
Why?
Gene Expression Regulation
4
2004
2651
0.040
Why?
Research Design
1
2023
746
0.040
Why?
Specialization
1
2019
82
0.040
Why?
Cell Cycle Proteins
1
2002
697
0.040
Why?
Expert Testimony
1
2018
37
0.040
Why?
Quality Improvement
1
2024
691
0.040
Why?
Anesthetics, Local
1
2019
91
0.040
Why?
Health Care Surveys
1
2019
293
0.040
Why?
Hemorrhage
1
2021
508
0.040
Why?
Carcinoma
1
2000
322
0.040
Why?
Caveolins
1
1997
15
0.030
Why?
Models, Genetic
1
2000
789
0.030
Why?
Multimodal Imaging
1
2018
112
0.030
Why?
European Union
1
2016
13
0.030
Why?
Infant
2
2011
13158
0.030
Why?
Emergency Medical Services
1
2021
414
0.030
Why?
Anticoagulants
1
2021
599
0.030
Why?
Tomography, X-Ray Computed
1
2024
2171
0.030
Why?
Gene Expression
1
2001
1614
0.030
Why?
Internet
1
2019
403
0.030
Why?
Enzyme-Linked Immunosorbent Assay
1
2018
866
0.030
Why?
Delivery of Health Care
1
2022
676
0.030
Why?
Drug Substitution
1
2015
20
0.030
Why?
Voriconazole
1
2014
34
0.030
Why?
Prosthesis Design
1
2017
658
0.030
Why?
COS Cells
2
2004
283
0.030
Why?
Survival Analysis
3
2003
1596
0.030
Why?
Logistic Models
1
2019
1907
0.030
Why?
Cell Transformation, Neoplastic
1
1997
644
0.030
Why?
Recombinant Proteins
1
1997
1437
0.030
Why?
Observer Variation
1
2014
312
0.030
Why?
Drug-Related Side Effects and Adverse Reactions
1
2016
282
0.030
Why?
Light Coagulation
1
2013
24
0.030
Why?
RNA, Neoplasm
2
2004
144
0.030
Why?
Visual Fields
1
2014
147
0.030
Why?
Nevus
1
2013
35
0.030
Why?
Skin Neoplasms
1
2000
903
0.030
Why?
Hyperthermia, Induced
1
2013
59
0.030
Why?
Immunoenzyme Techniques
2
2002
258
0.020
Why?
Hemangioma
1
2013
97
0.020
Why?
Retinoblastoma
1
2013
117
0.020
Why?
Child, Preschool
2
2022
14788
0.020
Why?
Mass Screening
1
2018
834
0.020
Why?
Retinal Neoplasms
1
2013
103
0.020
Why?
Models, Theoretical
1
2014
397
0.020
Why?
Radiation Injuries
1
2013
165
0.020
Why?
Neoplasms, Multiple Primary
1
2012
72
0.020
Why?
Enzyme Induction
2
2001
104
0.020
Why?
Microbial Sensitivity Tests
1
2014
826
0.020
Why?
Diabetes Mellitus, Type 1
1
2019
867
0.020
Why?
Prevalence
1
2016
2651
0.020
Why?
Coloring Agents
1
2009
78
0.020
Why?
Fluorescence
1
2009
103
0.020
Why?
Membrane Proteins
1
1997
1603
0.020
Why?
Response Elements
2
1999
106
0.020
Why?
Diabetes Mellitus, Type 2
1
2019
1405
0.020
Why?
Syndrome
1
2009
1158
0.020
Why?
Hypoxia-Inducible Factor-Proline Dioxygenases
1
2004
22
0.010
Why?
Procollagen-Proline Dioxygenase
1
2004
36
0.010
Why?
Immune Sera
1
2004
95
0.010
Why?
Mixed Function Oxygenases
1
2004
35
0.010
Why?
Immediate-Early Proteins
1
2004
60
0.010
Why?
Tissue Distribution
1
2004
400
0.010
Why?
Doxycycline
1
2004
121
0.010
Why?
Survival
1
2003
19
0.010
Why?
Microscopy, Fluorescence
1
2004
336
0.010
Why?
Animals
5
2004
36377
0.010
Why?
Apoptosis
2
2002
1928
0.010
Why?
Receptors, Antigen, B-Cell
1
2002
33
0.010
Why?
Glucose Transporter Type 1
1
2002
26
0.010
Why?
RNA Probes
1
2002
31
0.010
Why?
RNA Interference
1
2004
543
0.010
Why?
Isoenzymes
1
2003
231
0.010
Why?
Monosaccharide Transport Proteins
1
2002
43
0.010
Why?
In Situ Nick-End Labeling
1
2002
128
0.010
Why?
RNA, Small Interfering
1
2004
714
0.010
Why?
Down-Regulation
1
2004
717
0.010
Why?
Thymidine Phosphorylase
1
2001
13
0.010
Why?
Mice, Inbred BALB C
1
2004
1079
0.010
Why?
Mucin-1
1
2001
37
0.010
Why?
Fibroblast Growth Factor 2
1
2001
53
0.010
Why?
DNA Primers
1
2002
669
0.010
Why?
England
1
2001
72
0.010
Why?
Drug Therapy
1
2001
93
0.010
Why?
Protein Kinases
1
2002
343
0.010
Why?
Nephrectomy
1
2002
180
0.010
Why?
Radiotherapy
1
2001
148
0.010
Why?
Endothelium, Vascular
1
2003
522
0.010
Why?
Antigens, CD
1
2002
452
0.010
Why?
ErbB Receptors
1
2001
302
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2002
1326
0.010
Why?
Mice
3
2004
18910
0.010
Why?
Cobalt
1
1999
18
0.010
Why?
Iron Chelating Agents
1
1999
15
0.010
Why?
Multivariate Analysis
1
2003
1488
0.010
Why?
Disease-Free Survival
1
2001
971
0.010
Why?
Cell Line
1
2004
2836
0.010
Why?
Multienzyme Complexes
1
1999
88
0.010
Why?
Adaptor Proteins, Signal Transducing
1
2002
619
0.010
Why?
Transcription, Genetic
1
2004
1755
0.010
Why?
Cysteine Endopeptidases
1
1999
119
0.010
Why?
Infant, Newborn
1
2011
8586
0.010
Why?
Proteasome Endopeptidase Complex
1
1999
271
0.010
Why?
Receptor, ErbB-2
1
2001
559
0.010
Why?
Survival Rate
1
2003
2210
0.010
Why?
Genes, fos
1
1997
15
0.010
Why?
Mammals
1
1999
277
0.010
Why?
3T3 Cells
1
1997
122
0.010
Why?
Caveolin 1
1
1997
50
0.010
Why?
HeLa Cells
1
1999
828
0.010
Why?
Carrier Proteins
1
2002
1066
0.010
Why?
Genes, ras
1
1997
102
0.010
Why?
Neoplasm Staging
1
2001
1384
0.010
Why?
Drug Resistance, Neoplasm
1
2001
819
0.010
Why?
Predictive Value of Tests
1
2001
2294
0.010
Why?
Lung
1
2003
1557
0.010
Why?
Transcriptional Activation
1
1997
497
0.010
Why?
Adenocarcinoma
1
2001
1070
0.010
Why?
WYKOFF's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (522)
Explore
_
Co-Authors (4)
Explore
_
Similar People (58)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_